Metropolitan Life Insurance Company (MetLife)’s DermTech, Inc. Common Stock DMTK Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,598	Closed	-$23.5K	–	2450
2022 Q1	$23.5K	Sell	1,598 -5,173	-76%	-$69.2K	﹤0.01%	2015
2021 Q4	$107K	Hold	6,771	–	–	﹤0.01%	2438
2021 Q3	$217K	Hold	6,771	–	–	﹤0.01%	2010
2021 Q2	$281K	Buy	6,771 +3,647	+117%	+$150K	﹤0.01%	1904
2021 Q1	$159K	Buy	+3,124	New	+$163K	﹤0.01%	2176

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s DMTK Position: Q2 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 1,598 shares — an estimated $23.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DMTK in Q1 2021 and held it in 5 quarters. The position peaked at $281K in Q2 2021. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,598 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $23.5K.
Metropolitan Life Insurance Company (MetLife) first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Metropolitan Life Insurance Company (MetLife)'s DermTech, Inc. Common Stock position peaked at $281K in Q2 2021.
134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.